BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 20876809)

  • 1. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
    Ning BF; Ding J; Yin C; Zhong W; Wu K; Zeng X; Yang W; Chen YX; Zhang JP; Zhang X; Wang HY; Xie WF
    Cancer Res; 2010 Oct; 70(19):7640-51. PubMed ID: 20876809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
    Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-negative feedback loop between Wnt-β-catenin signaling and HNF4α regulates epithelial-mesenchymal transition in hepatocellular carcinoma.
    Yang M; Li SN; Anjum KM; Gui LX; Zhu SS; Liu J; Chen JK; Liu QF; Ye GD; Wang WJ; Wu JF; Cai WY; Sun GB; Liu YJ; Liu RF; Zhang ZM; Li BA
    J Cell Sci; 2013 Dec; 126(Pt 24):5692-703. PubMed ID: 24101726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte nuclear factor 4alpha attenuates hepatic fibrosis in rats.
    Yue HY; Yin C; Hou JL; Zeng X; Chen YX; Zhong W; Hu PF; Deng X; Tan YX; Zhang JP; Ning BF; Shi J; Zhang X; Wang HY; Lin Y; Xie WF
    Gut; 2010 Feb; 59(2):236-46. PubMed ID: 19671543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tg737 regulates epithelial-mesenchymal transition and cancer stem cell properties via a negative feedback circuit between Snail and HNF4α during liver stem cell malignant transformation.
    Huang Q; Pu M; Zhao G; Dai B; Bian Z; Tang H; Chen C; Liu W; Qu X; Shen L; Tao K
    Cancer Lett; 2017 Aug; 402():52-60. PubMed ID: 28536011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatocyte nuclear factor 4 (HNF4) in epithelial development and carcinogenesis].
    Lazarevich NL; Al'pern DV
    Mol Biol (Mosk); 2008; 42(5):786-97. PubMed ID: 18988528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of hepatocyte nuclear factor 4 (HNF4)as a marker of epithelial tumors progression.
    Lazarevich NL; Shavochkina DA; Fleishman DI; Kustova IF; Morozova OV; Chuchuev ES; Patyutko YI
    Exp Oncol; 2010 Sep; 32(3):167-71. PubMed ID: 21403612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.
    Yin C; Lin Y; Zhang X; Chen YX; Zeng X; Yue HY; Hou JL; Deng X; Zhang JP; Han ZG; Xie WF
    Hepatology; 2008 Nov; 48(5):1528-39. PubMed ID: 18925631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression.
    Ning BF; Ding J; Liu J; Yin C; Xu WP; Cong WM; Zhang Q; Chen F; Han T; Deng X; Wang PQ; Jiang CF; Zhang JP; Zhang X; Wang HY; Xie WF
    Hepatology; 2014 Nov; 60(5):1607-19. PubMed ID: 24752868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte nuclear factor-4α reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region.
    Yin C; Wang PQ; Xu WP; Yang Y; Zhang Q; Ning BF; Zhang PP; Zhou WP; Xie WF; Chen WS; Zhang X
    Hepatology; 2013 Dec; 58(6):1964-76. PubMed ID: 23775631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.
    Park MY; Kim KR; Park HS; Park BH; Choi HN; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
    Int J Oncol; 2007 Dec; 31(6):1309-15. PubMed ID: 17982656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
    Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W
    Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of transforming growth factor-alpha in cirrhosis, dysplastic nodules, and hepatocellular carcinoma: an immunohistochemical study of 70 cases.
    Yeh MM; Larson AM; Campbell JS; Fausto N; Rulyak SJ; Swanson PE
    Am J Surg Pathol; 2007 May; 31(5):681-9. PubMed ID: 17460450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma.
    Vallianou I; Dafou D; Vassilaki N; Mavromara P; Hadzopoulou-Cladaras M
    Int J Biochem Cell Biol; 2016 Sep; 78():315-326. PubMed ID: 27477312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
    Xu L; Hui L; Wang S; Gong J; Jin Y; Wang Y; Ji Y; Wu X; Han Z; Hu G
    Cancer Res; 2001 Apr; 61(7):3176-81. PubMed ID: 11306505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
    Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
    J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis signal-regulating kinase 1 mediates the inhibitory effect of hepatocyte nuclear factor-4α on hepatocellular carcinoma.
    Jiang CF; Wen LZ; Yin C; Xu WP; Shi B; Zhang X; Xie WF
    Oncotarget; 2016 May; 7(19):27408-21. PubMed ID: 27050273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma.
    Nagata K; Hirono S; Ido A; Kataoka H; Moriuchi A; Shimomura T; Hori T; Hayashi K; Koono M; Kitamura N; Tsubouchi H
    Biochem Biophys Res Commun; 2001 Nov; 289(1):205-11. PubMed ID: 11708800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stable repression of mesenchymal program is required for hepatocyte identity: a novel role for hepatocyte nuclear factor 4α.
    Santangelo L; Marchetti A; Cicchini C; Conigliaro A; Conti B; Mancone C; Bonzo JA; Gonzalez FJ; Alonzi T; Amicone L; Tripodi M
    Hepatology; 2011 Jun; 53(6):2063-74. PubMed ID: 21384409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.
    Schoedel KE; Tyner VZ; Kim TH; Michalopoulos GK; Mars WM
    Mod Pathol; 2003 Jan; 16(1):14-21. PubMed ID: 12527708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.